Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

Published:2012-11-30 Issue:12 Volume:53 Page:1883-1891
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Cho Steve Y.,Gage Kenneth L.,Mease Ronnie C.,Senthamizhchelvan Srinivasan,Holt Daniel P.,Jeffrey-Kwanisai Akimosa,Endres Christopher J.,Dannals Robert F.,Sgouros George,Lodge Martin,Eisenberger Mario A.,Rodriguez Ronald,Carducci Michael A.,Rojas Camilo,Slusher Barbara S.,Kozikowski Alan P.,Pomper Martin G.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference39 articles.

1. Cancer Statistics, 2010

2. Prostate Cancer: A Practical Approach to Current Management of Recurrent Disease

3. New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety

4. Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen

5. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation and Pilot Clinical Study of ¹⁸F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2;ACS Pharmacology & Translational Science;2024-05-24

2. Clinical Positron Emission Tomography/Computed Tomography;PET Clinics;2024-04

3. Knowledge mapping of application of image-guided surgery in prostate cancer: a bibliometric analysis (2013–2023);International Journal of Surgery;2024-03-04

4. Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen–Based Therapies for Prostate Cancer;Journal of Clinical Oncology;2024-03-01

5. Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection;Theranostics;2024